Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 2.808\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] CN(C)c1nc(OCCNC(=O)Nc2ccccc2)nc(N2CCCCC2)n1
[b] O=C(O)C(=O)O.Oc1ccccc1NCC(O)Cn1ccc2ccccc21
[c] CCOc1cc(N2CCOCC2)c(OCC)cc1NC(=O)COc1ncnc2ccccc12
[d] CC(C)c1ccc(/C=C/C(=O)Nc2ccc(CN3CCOCC3)cc2)cc1
[e] CCC(C)N1CNc2c(c(=O)[nH]c(=S)n2-c2cccc(C)c2)C1
Answer: e. CCC(C)N1CNc2c(c(=O)[nH]c(=S)n2-c2cccc(C)c2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)N1CNc2c(c(=O)[nH]c(=S)n2-c2cccc(C)c2)C1
CCC(C)N1CNc2c(c(=O)[nH]c(=S)n2-c2cccc(C)c2)C1
6-butan-2-yl-1-(3-methylphenyl)-2-sulfanylidene-7,8-dihydro-5H-pyrimido[4,5-d]pyrimidin-4-one